Immunome
IMNM
IMNM
120 hedge funds and large institutions have $566M invested in Immunome in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.57% less ownership
Funds ownership: 85.98% → 85.41% (-0.57%)
25% less capital invested
Capital invested by funds: $755M → $566M (-$188M)
98% less call options, than puts
Call options by funds: $439K | Put options by funds: $21.9M
Holders
120
Holding in Top 10
3
Calls
$439K
Puts
$21.9M
Top Buyers
| 1 | +$8.52M | |
| 2 | +$6.63M | |
| 3 | +$3.34M | |
| 4 |
Renaissance Technologies
New York
|
+$3.24M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.97M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$12.6M | |
| 3 | -$10.7M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$10.5M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$6.58M |